A Challenging Form of Epilepsy Seizure Types in LGS LGS Patient ProfilesPivotal Trial Design
Efficacy of BANZEL® in Seizure Reduction Seizure Severity Rating Responder RatesAdverse ReactionsMechanism of Action/PharmacokineticsDrug InteractionsDosing BANZEL® Connect
BANZEL is indicated for adjunctive treatment of seizures associated with
Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older,
and in adults.